The world needs a global plan to tackle antimicrobial resistance. Alongside a $2B fund to jump-start innovation there should be a $1B reward for companies when a new antibiotic is launched, says Jim O’Neill, chair of the review
GSK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-term ambition to jointly deliver new medicine to patients in the next 5-10 years
An improved gene therapy treatment can cure mice with cystic fibrosis (CF). Cell cultures from CF patients, too, respond well to the treatment. Those are the encouraging results of a study presented by the KU Leuven Laboratory for Molecular Virology and Gene Therapy.
The London Project to Cure Blindness reported completion of the first procedure to implant a patch seeded with retinal cells derived from an embryo. The treatment is for macular degeneration, a leading cause of vision loss
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.